نتایج جستجو برای: tyrosine kinase inhibitor

تعداد نتایج: 426607  

2016
Youngjoo Lee Yu-Ra Choi Kyoung-Yeon Kim Dong Hoon Shin

Drug-resistant cell lines are essential tools for investigating the mechanisms of resistance to molecular-targeted anti-cancer drugs. However, little is known about how to establish clinically relevant drug-resistant cell lines. Our study examined the impact of a drug-free period on the establishment of a cell line with clinically relevant resistance to molecular-targeted drugs. We used PC9 cel...

2015
Beatriz Felicio Ribeiro Eliana C M Miranda Dulcinéia Martins de Albuquerque Márcia T Delamain Gislaine Oliveira-Duarte Maria Helena Almeida Bruna Vergílio Rosana Antunes da Silveira Vagner Oliveira-Duarte Irene Lorand-Metze Carmino A De Souza Katia B B Pagnano

OBJECTIVE To evaluate hematological, cytogenetic and molecular responses as well as the overall, progression-free and event-free survivals of chronic myeloid leukemia patients treated with a third tyrosine kinase inhibitor after failing to respond to imatinib and nilotinib/dasatinib. METHODS Bone marrow karyotyping and real-time quantitative polymerase chain reaction were performed at baselin...

Journal: :Cancer research 2002
David Wisniewski Caryl L Lambek Chongyuan Liu Annabel Strife Darren R Veach Bhushan Nagar Matthew A Young Thomas Schindler William G Bornmann Joseph R Bertino John Kuriyan Bayard Clarkson

The early stage of chronic myelogenous leukemia (CML) is caused by the tyrosine kinase Bcr-Abl. Imatinib mesylate (also known as STI-571 and Gleevec), a tyrosine kinase inhibitor, has shown encouraging results in CML clinical trials and has become a paradigm for targeted cancer therapeutics. Recent reports of resistance to imatinib argue for further development of therapies for CML. During stud...

Journal: :The Journal of pharmacology and experimental therapeutics 1999
A Banes J A Florian S W Watts

5-Hydroxytryptamine (5-HT) activates the extracellular signal-regulated kinase (Erk) mitogen-activated protein kinases (MAPKs) in the vasculature, resulting in contraction. The mechanisms by which this occurs are unclear. G protein-coupled receptors can activate Erk MAPK pathways through a variety of mechanisms, including stimulation of Src, phosphoinositide-3 kinase (PI-3-K), protein kinase C ...

2013
Dong M. Shin Hongzheng Zhang Nabil F. Saba Amy Y. Chen Sreenivas Nannapaneni Melinda Lewis Gabriel Sica Scott Kono Johann C. Brandes William J. Grist Rachel Moreno-Williams Jonathan J. Beitler Sufi M. Thomas Zhengjia Chen Hyung Ju C. Shin Jennifer R. Grandis Fadlo R. Khuri Zhuo Georgia Chen

Purpose:We investigated the efficacy and underlyingmolecularmechanism of a novel chemopreventive strategy combining EGF receptor (EGFR) tyrosine kinase inhibitor (TKI) with cyclooxygenase-2 inhibitor

Journal: :American journal of physiology. Heart and circulatory physiology 2002
Liyan Miao Yun Dai John Zhang

This study was undertaken to demonstrate the role of the RhoA/Rho kinase pathway in endothelin-1 (ET-1)-induced contraction of the rabbit basilar artery. Isometric tension and Western blot were used to examine ET-1-induced contraction and RhoA activation. The upstream effect on ET-1-induced RhoA activity was determined by using ET(A) and ET(B) receptor antagonists, protein kinase C (PKC), tyros...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید